D. Rondelli

R. Hoffman, J. Prchal, S. Ciurea, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Standard chronic immunosuppression after kidney transplantation for systemic lupus erythematosus eliminates recurrence of disease

E. Benedetti, G. Testa, F. Panaro, 2005, Clinical transplantation.

Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR Outcomes.

P. Bierman, I. Flinn, C. Flowers, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Antitumor vaccination: where we stand.

M. Colombo, G. Forni, M. Di Nicola, 2000, Haematologica.

Expression of P21WAF1/CIP1/SID1 cyclin-dependent kinase inhibitor in hematopoietic progenitor cells

G. Brusa, L. Pattacini, E. Barbieri, 2001 .

Allo-SCT for myelofibrosis: reversing the chronic phase in the JAK inhibitor era?

R. Hoffman, J. Prchal, J. Mascarenhas, 2015, Bone Marrow Transplantation.

Human hematopoietic CD34+ progenitor cells induce natural killer cell alloresponses via NKG2D activation.

A. Steinle, D. Rondelli, B. Nicolini, 2016, Experimental hematology.

Superior Survival in African American Patients Who Underwent Autologous Stem Cell Transplantation for Multiple Myeloma.

D. Rondelli, G. Calip, K. Sweiss, 2019, Clinical lymphoma, myeloma & leukemia.

GenesExpression of Selected Immune Response Autoimmune Diabetes and Modifies the Allogeneic Newborn Blood Ameliorates Transfusion of Nonobese Diabetic Mice with

B. Prabhakar, Rebecca M. Garza, D. Rondelli, 2010 .

The experience of adults with sickle cell disease and their HLA-matched adult sibling donors after allogeneic hematopoietic stem cell transplantation.

Kathryn Knafl, S. Saraf, D. Rondelli, 2019, Journal of Advanced Nursing.

Effects of extensive splenomegaly in patients with myelofibrosis undergoing a reduced intensity allogeneic stem cell transplantation

R. Hoffman, L. Akard, S. Ciurea, 2008, British journal of haematology.

Alloantigen presenting capacity, T cell alloreactivity and NK function of G-CSF-mobilized peripheral blood cells

F. Re, C. Anasetti, S. Tura, 1998, Bone Marrow Transplantation.

Improved health care utilization and costs in transplanted versus non-transplanted adults with sickle cell disease

V. Gordeuk, R. Molokie, S. Saraf, 2020, PloS one.

Chromatin-Modifying Agent–Expanded Human Cord Blood Cells Display Reduced Allostimulatory Capacity

N. Mahmud, D. Mahmud, D. Rondelli, 2019, The Journal of Immunology.

Human CD4(+)CD25(+) Cells in Combination with CD34(+) Cells and Thymoglobulin to Prevent Anti-hematopoietic Stem Cell T Cell Alloreactivity.

N. Mahmud, D. Mahmud, D. Rondelli, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Rapid Induction of CD 40 on a Subset of Granulocyte Colony-Stimulating Factor – Mobilized CD 34 1 Blood Cells Identifies Myeloid Committed Progenitors and Permits Selection of Nonimmunogenic CD 40 2 Progenitor Cells

S. Tura, A. Curti, M. Ratta, 1999 .

Rapid induction of CD40 on a subset of granulocyte colony-stimulating factor-mobilized CD34(+) blood cells identifies myeloid committed progenitors and permits selection of nonimmunogenic CD40(-) progenitor cells.

F. Re, S. Tura, A. Curti, 1999, Blood.

Allogeneic Hematopoietic Stem Cell Transplantation for Adults with Sickle Cell Disease

S. Saraf, D. Rondelli, 2019, Journal of clinical medicine.

Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations.

J. Dipersio, R. Soiffer, R. Negrin, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Selective apoptosis of monocytes and monocyte-derived DCs induced by bortezomib (Velcade)

C. Agostinelli, D. Rondelli, B. Nicolini, 2009, Bone Marrow Transplantation.

Different immune reconstitution in multiple myeloma, chronic myeloid leukemia and acute myeloid leukemia patients after allogeneic transplantation of peripheral blood stem cells

F. Re, S. Tura, F. Bonifazi, 2000, Bone Marrow Transplantation.

The need for locally generated data in haematology: a real‐world experience of aplastic anaemia in Nepal

B. Gyawali, D. Rondelli, Bishesh Sharma Poudyal, 2020, British journal of haematology.

Enhancement of T cell activation by immobilized hu5C8 (anti‐CD40L) monoclonal antibody

D. Rondelli, M. Arpinati, G. Chirumbolo, 2008, European journal of haematology.

T Cell-Mediated Rejection of Human CD34+ Cells Is Prevented by Costimulatory Blockade in a Xenograft Model.

N. Mahmud, D. Mahmud, J. Ferrara, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Gastrointestinal Mantle Cell Lymphoma: incidental finding on routine CT scan following pneumothorax.

M. Sherpa, D. Rondelli, Raksha Shrestha, 2013 .

The constitutive mobilization of bone marrow-repopulating cells into the peripheral blood in idiopathic myelofibrosis.

N. Mahmud, R. Hoffman, G. Barosi, 2005, Blood.

Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group

M. Griesshammer, N. Kröger, T. Barbui, 2015, Leukemia.

Life-Threatening Tumor Lysis Syndrome Within 12 Hours of a Single Dose of Corticosteroid in a Patient with Lymphoma

J. Levine, J. Arruda, K. Perumal, 2009 .

Selective expansion of normal haemopoietic progenitors from chronic myelogenous leukaemia marrow

G. Martinelli, S. Tura, A. Curti, 1998, British journal of haematology.

JAK Inhibitors and Allogeneic Stem Cell Transplantation for Myelofibrosis

H. Deeg, J. Radich, S. Verstovsek, 2015 .

Janus kinase inhibitors and allogeneic stem cell transplantation for myelofibrosis.

H. Deeg, J. Radich, N. Kröger, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis.

V. Najfeld, R. Hoffman, G. Barosi, 2014, Blood.

Single agent bevacizumab for myelofibrosis: results of the Myeloproliferative Disorders Research Consortium Trial

S. Verstovsek, R. Hoffman, R. Mesa, 2013, Haematologica.

Allogeneic hematopoietic stem cell transplantation for myelofibrosis

D. Rondelli, 2008, Haematologica.

Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasia.

R. Hoffman, B. Smith, G. Barosi, 2005, Blood.

Use of anti-BDCA-2 antibody for detection of dendritic cells type-2 (DC2) in allogeneic hematopoietic stem cell transplantation

M. Baccarani, S. Tura, F. Bonifazi, 2002, Bone Marrow Transplantation.

Dendritic cells Use of anti-BDCA-2 antibody for detection of dendritic cells type-2 (DC2) in allogeneic hematopoietic stem cell transplantation

M. Baccarani, S. Tura, F. Bonifazi, 2002 .

Constitutional Symptoms Masking COVID-19 In A Patient with Primary Myelofibrosis

D. Rondelli, M. Khan, C. Schwartz, 2020 .

Development of a method for clinical pharmacokinetic testing to allow for targeted Melphalan dosing in multiple myeloma patients undergoing autologous transplant

C. Hofmeister, N. Mahmud, B. Vemu, 2020, British journal of clinical pharmacology.

Polypharmacy and potentially inappropriate medication use is highly prevalent in multiple myeloma patients and is improved by a collaborative physician–pharmacist clinic

D. Rondelli, G. Calip, K. Sweiss, 2019, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.

Amanda M Li, A. Kernytsky, D. Altshuler, 2020, The New England journal of medicine.

PARP inhibition synergizes with melphalan but does not reverse resistance completely.

N. Mahmud, D. Pan, D. Rondelli, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Plerixafor given before the third leukapheresis to rescue an unsuccessful stem cell mobilization with CY and G-CSF

N. Mahmud, D. Rondelli, K. Sweiss, 2010, Bone Marrow Transplantation.

Cycling Status of CD 34 " Cells Mobilized Into Peripheral Blood of Healthy Donors by Recombinant Human Granulocyte Colony-Stimulating Factor

M. R. Ricciardi, A. Tafuri, S. Tura, 1997 .

Does post-transplant treatment with imatinib mesylate inhibit graft-versus-leukemia?

S. Kadkol, D. Rondelli, S. Chunduri, 2005, Leukemia.

Familial Childhood Monosomy 7 and Associated Myelodysplasia

D. Rondelli, R. Angeles, S. Gaitonde, 2010, Journal of pediatric hematology/oncology.

Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myeloﬁbrosis with myeloid metaplasia

R. Hoffman, B. Smith, G. Barosi, 2005 .

Why Do I Still Have a Bruise Around My Knee

D. Rondelli, S. Abutalib, V. Lindgren, 2008 .

Comparable kinetics of myeloablation between fludarabine/full-dose busulfan and fludarabine/melphalan conditioning regimens in allogeneic peripheral blood stem cell transplantation

N. Mahmud, R. Hoffman, Y. Saunthararajah, 2006, Bone Marrow Transplantation.

Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide

M. Cazzola, H. Deeg, R. Schlenk, 2020, Leukemia.

Race/ethnicity and underlying disease influences hematopoietic stem/progenitor cell mobilization response: A single center experience

N. Mahmud, D. Peace, C. Uzoka, 2021, Journal of clinical apheresis.

Blockade of TNFα to Improve Human CD34+ Cell Repopulating Activity in Allogeneic Stem Cell Transplantation

N. Mahmud, D. Rondelli, P. Patel, 2019, Front. Immunol..

Ex vivo expansion of human mobilized peripheral blood stem cells using epigenetic modifiers

N. Mahmud, S. Saraf, D. Rondelli, 2011, Transfusion.

Evaluation of Genotoxicity of Chromatin Modifying Agents Expanded Hematopoietic Graft in a Non-Human Primate Model.

N. Mahmud, J. Quigley, D. Rondelli, 2012 .

Acute graft-versus-host disease and steroid treatment impair CD11c+ and CD123+ dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation.

M. Baccarani, Y. Saunthararajah, S. Tura, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Plasmacytoid dendritic cells: do they have a role in immune responses after hematopoietic cell transplantation?

C. Anasetti, M. Rossi, D. Rondelli, 2002, Human immunology.

Low doses of rIL2 after autologous bone marrow transplantation induce a “prolonged” immunostimulation of NK compartment in high-grade non-Hodgkin's lymphomas

P. Tazzari, S. Ferrini, S. Tura, 1995, Annals of Hematology.

Human CD34(+) blood cells induce T-cell unresponsiveness to specific alloantigens only under costimulatory blockade.

M. Baccarani, F. Re, S. Tura, 2003, Experimental hematology.

A Phase I/II Placebo-Controlled Randomized Pilot Clinical Trial of Recombinant Deoxyribonuclease (DNase) Eye Drops Use in Patients With Dry Eye Disease

Yi-fan Chen, A. Pradeep, D. Rondelli, 2019, Translational vision science & technology.

Clinical Trials A Phase I / II Placebo-Controlled Randomized Pilot Clinical Trial of Recombinant Deoxyribonuclease ( DNase ) Eye Drops Use in Patients With Dry Eye Disease

Yi-fan Chen, A. Pradeep, D. Rondelli, 2019 .

Generation and functional characterization of human dendritic cells derived from CD34+ cells mobilized into peripheral blood: comparison with bone marrow CD34+ cells

G. Martinelli, S. Tura, F. Fagnoni, 1998, British journal of haematology.

Allostimulatory activity of CD133+ hematopoietic cells

N. Mahmud, D. Mahmud, D. Rondelli, 2013, Bone Marrow Transplantation.

Myeloperoxidase expression by histiocytes in Kikuchi's and Kikuchi-like lymphadenopathy.

S. Pileri, B. Falini, S. Ascani, 2001, The American journal of pathology.

Cells Progenitor - Progenitors and Permits Selection of Nonimmunogenic CD40 Mobilized CD34+ Blood Cells Identifies Myeloid Committed - Factor Rapid Induction of CD40 on a Subset of Granulocyte Colony-Stimulating

Mário, A. Curti, M. Ratta, 2013 .

D. Rondelli, G. Calip, K. Sweiss, 2018, Bone Marrow Transplantation.

Synergistic Cytotoxic Effect of Busulfan and the PARP Inhibitor Veliparib in Myeloproliferative Neoplasms.

N. Mahmud, D. Mahmud, D. Rondelli, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Renal dysfunction within 90 days of FluBu4 predicts early and late mortality

D. Rondelli, G. Calip, K. Sweiss, 2018, Bone Marrow Transplantation.

Allogeneic graft CD34(+) cell dose correlates with dendritic cell dose and clinical outcome, but not with dendritic cell reconstitution after transplant.

M. Baccarani, S. Tura, F. Bonifazi, 2003, Experimental hematology.

Expression of adhesion molecules on acute leukemic blast cells and sensitivity to normal LAK activity

S. Tura, D. Rondelli, F. Lauria, 1993, Annals of Hematology.

Continuous infusion of interleukin-2 in two relapsed high grade non-Hodgkin lymphoma patients: effectiveness and tolerability.

P. Zinzani, S. Tura, D. Rondelli, 1991, European journal of cancer.

Increased Donor CD86+CD14+ Cells in the Bone Marrow and Peripheral Blood of Patients With Chronic Graft-Versus-Host Disease

M. Baccarani, D. Rondelli, M. Arpinati, 2008, Transplantation.

Higher numbers of blood CD14+ cells before starting conditioning regimen correlate with greater risk of acute graft-versus-host disease in allogeneic stem cell transplantation from related donors.

M. Baccarani, Y. Saunthararajah, F. Bonifazi, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Acute Graft-versus-Host Disease and Steroid Treatment Impair CD11c (cid:1) and CD123 (cid:1) Dendritic Cell Reconstitution after Allogeneic Peripheral Blood Stem Cell Transplantation

M. Baccarani, Y. Saunthararajah, S. Tura, 2004 .

Incidence and prognostic relevance of CD34 expression in acute myeloblastic leukemia: analysis of 141 cases.

S. Tura, G. Visani, A. de Vivo, 1997, Leukemia research.

Fludarabine in patients with advanced and/or resistant B‐chronic lymphocytic leukemia

R. Fanin, P. Galieni, P. Zinzani, 1993, European journal of haematology.

Fludarabine: an active agent in the treatment of previously-treated and untreated low-grade non-Hodgkin's lymphoma.

R. Fanin, P. Galieni, P. Zinzani, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

Results of Phase II Clinical Trial MPD-RC 101: Allogeneic Hematopoietic Stem Cell Transplantation Conditioned with Fludarabine/Melphalan in Patients with Myelofibrosis

V. Najfeld, R. Hoffman, G. Barosi, 2012 .

Studies of the site and distribution of CD34+ cells in idiopathic myelofibrosis.

R. Hoffman, G. Barosi, D. Rondelli, 2005, American journal of clinical pathology.

Liver biopsy findings following donor lymphocyte infusion.

G. Guzman, D. Rondelli, Shou-jin Wu, 2005, Archives of pathology & laboratory medicine.

Non‐myeloablative human leukocyte antigen‐matched related donor transplantation in sickle cell disease: outcomes from three independent centres

J. Tisdale, M. Hsieh, N. Jeffries, 2021, British journal of haematology.

2‐Chlorodeoxyadenosine in the treatment of relapsed/refractory chronic lymphoproliferative disorders

P. Galieni, P. Zinzani, P. Zinzani, 1997, European journal of haematology.

Acute lung injury associated with 5-fluorouracil and oxaliplatinum combined chemotherapy.

L. L. Agli, R. Trisolini, M. Patelli, 2001, The European respiratory journal.

Knowledge-based planning for multi-isocenter VMAT total marrow irradiation

K. Yenice, M. Koshy, B. Aydogan, 2022, Frontiers in Oncology.

Multipotent Mesenchymal Stem Cells with Immunosuppressive Activity Can Be Easily Isolated from Dental Pulp

Mario Calvitti, Francesco Alviano, V. Fossati, 2005, Transplantation.

Different reconstitution of peripheral blood lymphocytes and dendritic cells in liver and kidney transplant patients.

J. Oberholzer, G. Testa, F. Panaro, 2005, Transplantation proceedings.

Role of plasmacytoid dendritic cells in immunity and tolerance after allogeneic hematopoietic stem cell transplantation.

C. Anasetti, G. Perrone, D. Rondelli, 2003, Transplant immunology.

Tolerance and hematopoietic stem cell transplantation 50 years after Burnet's theory.

F. Locatelli, D. Rondelli, G. Burgio, 2000, Experimental hematology.

Rapid restoration of natural killer activity following treatment with 2‐chlorodeoxyadenosine in 22 patients with hairy‐cell leukemia

S. Tura, D. Rondelli, F. Lauria, 1994, European journal of haematology.

A prospective study of intravenous pentamidine for PJP prophylaxis in adult patients undergoing intensive chemotherapy or hematopoietic stem cell transplant

J. Quigley, I. Khan, S. Saraf, 2018, Bone Marrow Transplantation.

Splenomegaly in patients with primary or secondary myelofibrosis who are candidates for allogeneic hematopoietic cell transplantation: a Position Paper on behalf of the Chronic Malignancies Working Party of the EBMT.

T. Barbui, M. Robin, I. Yakoub-Agha, 2022, The Lancet. Haematology.

A Novel l-Asparaginase with low l-Glutaminase Coactivity Is Highly Efficacious against Both T- and B-cell Acute Lymphoblastic Leukemias In Vivo.

A. Lavie, Michael J. Schlicht, P. Van Vlierberghe, 2018, Cancer research.

Exon 8 splice site mutations in the gene encoding the E3-ligase CBL are associated with core binding factor acute myeloid leukemias

R. Hoffman, S. Ciurea, D. Rondelli, 2008 .

In vitro susceptibility of acute leukemia cells to the cytotoxic activity of allogeneic and autologous lymphokine activated killer (LAK) effectors: correlation with the rate and duration of complete remission and with survival.

R. Foà, D. Rondelli, F. Lauria, 1994, Leukemia.

Pegylated Interferon Alfa-2a for Polycythemia Vera or Essential Thrombocythemia Resistant or Intolerant to Hydroxyurea.

E. Papaemmanuil, J. Tripodi, V. Najfeld, 2019, Blood.

Reliability of a pretransplant i.v. BU test dose performed 2 weeks before myeloablative FluBu conditioning regimen

N. Mahmud, J. Quigley, D. Peace, 2010, Bone Marrow Transplantation.

Coactivity IsHighlyEfficaciousagainstBothT-and B-cell Acute Lymphoblastic Leukemias In Vivo

A. Lavie, Michael J. Schlicht, Y. Saunthararajah, 2018 .

Development of a clinical hematology and stem cell transplantation program to provide state-of-the-art and cost-effective treatment to patients: a successful collaboration between a medical college in India and a leading medical university in the United States.

D. Rondelli, S. Devadas, K. Kumari, 2019, Blood advances.

The impact of novel influenza A (H1N1) after hematopoietic SCT

D. Peace, D. Rondelli, K. Sweiss, 2010, Bone Marrow Transplantation.

Results of the Myeloproliferative Neoplasms - Research Consortium (MPN-RC) 112 Randomized Trial of Pegylated Interferon Alfa-2a (PEG) Versus Hydroxyurea (HU) Therapy for the Treatment of High Risk Polycythemia Vera (PV) and High Risk Essential Thrombocythemia (ET)

A. Mead, J. Tripodi, V. Najfeld, 2018, Blood.

Impact on MPN Symptoms and Quality of Life of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia: Results of Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial

R. Schlenk, A. Mead, T. Barbui, 2016, Blood.

Cell therapy: achievements and perspectives.

M. Colombo, F. Locatelli, C. Carlo-Stella, 1999, Haematologica.

Prolonged responses after autologous stem cell transplantation in African-American patients with multiple myeloma

N. Mahmud, R. Hoffman, Y. Saunthararajah, 2006, Bone Marrow Transplantation.

Epidemiology, Biology, and Outcome in Multiple Myeloma Patients in different Geographical Areas of the World

S. Saraf, D. Rondelli, P. Patel, 2012 .

Constitutive and Stimulated Production of Vegf by Human Megakaryoblastic Cell Lines: Effect on Proliferation and Signaling Pathway

V. Fossati, F. Alviano, C. Marchionni, 2005, International journal of immunopathology and pharmacology.

Impact of High-Molecular-Risk Mutations on Transplantation Outcomes in Patients with Myelofibrosis.

V. Najfeld, R. Levine, N. Zhang, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A Focused Review of the Pathogenesis, Diagnosis, and Management of Tumor Lysis Syndrome for the Interventional Radiologist

D. Rondelli, P. Patel, M. Friedman, 2015, Seminars in Interventional Radiology.

Allogeneic hematopoietic stem cells from sources other than bone marrow: biological and technical aspects.

Roberto, A. Tabilio, F. Bertolini, 1997, Haematologica.

Results in hairy‐cell leukemia patients treated with α‐interferon: Predictive prognostic factors

S. Pileri, E. Sabattini, P. Zinzani, 1992 .

Increased expression of myeloid antigen markers in adult acute lymphoblastic leukaemia patients: diagnostic and prognostic implications

G. Martinelli, S. Tura, P. Tosi, 1994, British journal of haematology.

Molecular evaluation of clonal remission in hairy cell leukemia patients treated with 2-chlorodeoxyadenosine.

R. Foà, A. Carbone, P. F. di Celle, 1994, Leukemia & lymphoma.

Alloantigen Presenting Function of Normal Human CD34+ Hematopoietic Cells

J. Hansen, C. Anasetti, R. Ryncarz, 1996 .

Alloantigen presenting function of normal human CD34+ hematopoietic cells.

C. Anasetti, R. Ryncarz, D. Rondelli, 1996, Blood.

Pulmonary extramedullary hematopoiesis in patients with myelofibrosis undergoing allogeneic stem cell transplantation

R. Hoffman, S. Ciurea, D. Rondelli, 2008, Haematologica.

CD11b+GR1+ myeloid cells secrete NGF and promote trigeminal ganglion neurite growth: implications for corneal nerve regeneration.

N. Mahmud, D. Mahmud, S. Gandhi, 2013, Investigative ophthalmology & visual science.

Antibodies reactive with neutrophils following allogeneic haematopoietic stem cell transplantation

F. Ricci, C. Tassi, R. Conte, 1999, European journal of haematology.

The dominant negative β isoform of the glucocorticoid receptor is uniquely expressed in erythroid cells expanded from polycythemia vera patients.

J. Godbold, R. Hoffman, A. Migliaccio, 2011, Blood.

Haploidentical Transplants: An Answer to Ethical Challenges on the Use of Preimplantation Donor Selection.

D. Rondelli, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Nonmyeloablative Stem Cell Transplantation with Alemtuzumab/Low-Dose Irradiation to Cure and Improve the Quality of Life of Adults with Sickle Cell Disease.

A. Pickard, N. Mahmud, J. Quigley, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Severe hemolytic anemia due to passenger lymphocytes after living‐related bowel transplant

G. Testa, F. Panaro, D. Rondelli, 2004, Clinical Transplantation.

Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor.

M. R. Ricciardi, A. Tafuri, S. Tura, 1997, Blood.

The use of blood conservation methods in addition to erythropoietin allows myeloablative allogeneic stem cell transplantation without the use of blood products

N. Mahmud, D. Peace, S. Ciurea, 2006, Bone Marrow Transplantation.

Haploidentical Peripheral Blood Stem Cell Transplantation Demonstrates Stable Engraftment in Adults with Sickle Cell Disease

N. Mahmud, J. Quigley, V. Gordeuk, 2018, Biology of Blood and Marrow Transplantation.

American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation.

J. Wagner, J. Bolaños-Meade, J. Tisdale, 2021, Blood advances.

Allogeneic Stem Cell Transplantation to cure Acute Myeloid Leukemia in elderly patients

S. Saraf, D. Rondelli, P. Patel, 2012 .

Risk score to predict event-free survival after hematopoietic cell transplant for sickle cell disease.

J. Wagner, J. Tisdale, J. Meerpohl, 2020, Blood.

Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study.

J. Wagner, J. Bolaños-Meade, J. Tisdale, 2019, The Lancet. Haematology.

Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complications.

P. Zinzani, P. Zinzani, G. Marotta, 1999, Haematologica.

Hairy-cell leukemia and alpha-interferon treatment: long-term responders.

P. Zinzani, S. Tura, M. Salvucci, 1997, Haematologica.

High complete remission rate in hairy cell leukemia treated with 2-chlorodeoxyadenosine.

P. Zinzani, P. Zinzani, S. Tura, 1993, Leukemia & lymphoma.

A comparison of four leukapheresis methods to harvest an optimal dose of CD34+ cells: A single center experience

N. Mahmud, Zhengjia Chen, D. Peace, 2022, European journal of haematology.

Transfusion of Nonobese Diabetic Mice with Allogeneic Newborn Blood Ameliorates Autoimmune Diabetes and Modifies the Expression of Selected Immune Response Genes

B. Prabhakar, Rajvir Singh, Rebecca M. Garza, 2010, The Journal of Immunology.

This information is current as Genes Expression of Selected Immune Response Autoimmune Diabetes and Modifies the Allogeneic Newborn Blood Ameliorates Transfusion of Nonobese Diabetic Mice with

B. Prabhakar, Rajvir Singh, Rebecca M. Garza, 2010 .

Reduced incidence of GVHD without increase in relapse with low-dose rabbit ATG in the preparative regimen for unrelated bone marrow transplants in CML

M. Baccarani, P. Tazzari, R. Conte, 2003, Bone Marrow Transplantation.

Preclinical IV busulfan dose-finding study to induce reversible myeloablation in a non-human primate model

N. Mahmud, D. Rondelli, L. Halliday, 2018, PloS one.

The presence of lymphoid‐associated antigens in adult acute myeloid leukemia is devoid of prognostic relevance

S. Tura, P. Tosi, N. Testoni, 1995, Stem cells.

Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.

G. Rosti, C. Tassi, R. Conte, 1998, Haematologica.

T cell alloreactivity induced by normal G-CSF-mobilized CD34+ blood cells

C. Anasetti, S. Tura, M. Ratta, 1998, Bone Marrow Transplantation.

Deferasirox increases BU blood concentrations

D. Rondelli, K. Sweiss, P. Patel, 2012, Bone Marrow Transplantation.

Drug Shortage Impacts Patient Receipt of Induction Treatment

J. Zwanziger, L. Powell, S. Crawford, 2018, Health services research.

Long-lasting complete remission in patients with hairy cell leukemia treated with 2-CdA: a 5-year survey

P. Zinzani, S. Tura, F. Forconi, 1997, Leukemia.

Safety and Efficacy of CTX001 in Patients with Transfusion-Dependent β-Thalassemia and Sickle Cell Disease: Early Results from the Climb THAL-111 and Climb SCD-121 Studies of Autologous CRISPR-CAS9-Modified CD34+ Hematopoietic Stem and Progenitor Cells

S. Grupp, S. Sheth, M. Cappellini, 2020 .

Combination of linear accelerator-based intensity-modulated total marrow irradiation and myeloablative fludarabine/busulfan: a phase I study.

R. Weichselbaum, N. Mahmud, D. Mahmud, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Interim Analysis of the Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential Thrombocythemia

R. Schlenk, A. Mead, T. Barbui, 2016 .

Allogeneic Hematopoietic Cell Transplantation and Other Expensive Cellular Therapies: A Miracle for the Few but Off Limits to Many?

H. Deeg, E. Kodish, N. Majhail, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia

A. Mead, J. Tripodi, V. Najfeld, 2022, Blood.

L. Hsu, S. Saraf, D. Rondelli, 2019, Western journal of nursing research.

Strength Training to Enhance Early Recovery after Hematopoietic Stem Cell Transplantation.

E. Hacker, E. Collins, C. Park, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Results of a fludarabine induction and α‐interferon maintenance protocol in pretreated patients with chronic lymphocytic leukemia and low‐grade non‐Hodgkin's lymphoma

P. Zinzani, E. Zamagni, S. Tura, 1997, European journal of haematology.

Long-term follow-up after fludarabine treatment in pretreated patients with chronic lymphocytic leukemia.

P. Zinzani, S. Tura, D. Rondelli, 2000, Haematologica.

Discrepancy between serological complete remission and concomitant new bone lytic lesions after infusion of escalating low doses of donor lymphocytes in multiple myeloma: a case report

F. Re, S. Tura, M. Cavo, 1999, Bone Marrow Transplantation.

Selection and transplantation of autologous CD34+ B‐lineage negative cells in advanced‐phase multiple myeloma patients: a pilot study

G. Martinelli, S. Tura, M. Cavo, 1999, British journal of haematology.

Worldwide Network for Blood and Marrow Transplantation (WBMT) Recommendations Regarding Essential Medications Required To Establish An Early Stage Hematopoietic Cell Transplantation Program.

N. Kröger, M. Perales, M. Mohty, 2021, Transplantation and cellular therapy.

Hematopoietic Stem Cell Transplantation in Nepal: international partnership, implementation steps and clinical outcomes.

N. Mahmud, D. Rondelli, K. Sweiss, 2022, Transplantation and cellular therapy.

Comorbidity index does not predict outcome in allogeneic myeloablative transplants conditioned with fludarabine/i.v. busulfan (FluBu4)

D. Rondelli, K. Sweiss, P. Patel, 2011, Bone Marrow Transplantation.

Big BU/CY is associated with a favorable long-term outcome in patients allotransplanted for chronic myelogenous leukemia in chronic phase

G. Rosti, S. Tura, N. Testoni, 1998, Bone Marrow Transplantation.

A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis

J. Tripodi, V. Najfeld, M. Arcasoy, 2019, Leukemia.

Pretransplant hemoglobin and creatinine clearance correlate with treatment-free survival after autologous stem cell transplantation for multiple myeloma

J. Johnson, D. Rondelli, G. Calip, 2019, Bone Marrow Transplantation.

Melphalan 200 mg/m2 in patients with renal impairment is associated with increased short-term toxicity but improved response and longer treatment-free survival

D. Rondelli, K. Sweiss, P. Patel, 2016, Bone Marrow Transplantation.

Allogeneic hsct with reduced intensity conditioning regimens in high risk patients with myelofibrosis

R. Hoffman, G. Barosi, J. Prchal, 2004 .

Non-myeloablative allogeneic stem cell transplant with post-transplant cyclophosphamide cures the first adult patient with congenital dyserythropoietic anemia

D. Rondelli, S. Mehendale, R. Chowdhery, 2017, Bone Marrow Transplantation.

Predictors of increased melphalan exposure correlate with overall survival, nonrelapse mortality, and toxicities in patients undergoing reduced-intensity allogeneic stem cell transplantation with fludarabine and melphalan

J. Johnson, D. Rondelli, G. Calip, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

JAK2 V617F Positive Essential Thrombocythemia Complicated by B-cell Chronic Lymphocytic Leukemia: An Uncommon Association and Diagnostic Pitfall

S. Kadkol, D. Rondelli, S. Mehendale, 2011 .

Biological characterization of CD34+ cells mobilized into peripheral blood.

A. Tafuri, S. Tura, L. Catani, 1998, Bone marrow transplantation.

Hematopoietic Cell Transplantation in Primary Myelofibrosis

I. Khan, D. Rondelli, 2014 .

The limited use of autologous hematopoietic stem cell transplant for fit older patients with multiple myeloma in India: a retrospective analysis

D. Rondelli, S. Devadas, S. Revannasiddaiah, 2022, Journal of the Egyptian National Cancer Institute.

Cytofluorimetric and functional analysis of c-kit receptor in acute leukemia.

L. Montanaro, P. Strippoli, L. Bonsi, 1995, Leukemia & lymphoma.

Alpha-interferon as maintenance drug after initial fludarabine therapy for patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma.

R. Fanin, F. Mandelli, P. Zinzani, 1994, Haematologica.

Serum soluble interleukin-2 receptor levels in hairy cell leukemia: correlation with clinical and hematological parameters and with alpha-interferon treatment.

S. Pileri, E. Sabattini, P. Zinzani, 1992, Leukemia & lymphoma.

Steps to Enhance Early Recovery After Hematopoietic Stem Cell Transplantation: Lessons Learned From a Physical Activity Feasibility Study

E. Hacker, D. Rondelli, P. Patel, 2018, Clinical nurse specialist CNS.

Persistent Fatigue in Hematopoietic Stem Cell Transplantation Survivors

G. Fantuzzi, E. Hacker, C. Park, 2017, Cancer nursing.

Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia: a new treatment schedule effective and safer in preventing infectious complications.

P. Zinzani, P. Zinzani, G. Marotta, 1997, Blood.

Long-lasting decrease of CD4+/CD45RA+T cells in HCL patients after 2-chlorodeoxyadenosine (2-CdA) treatment

G. Nardi, G. Marotta, D. Rondelli, 1999, Leukemia.

Cytomegalovirus: A possible cause of Persistent Refractory Immune Thrombocytopenic Purpura

M. Sherpa, D. Rondelli, Raksha Shrestha, 2014 .

CD7 expression does not affect the prognosis in acute myeloid leukemia.

S. Tura, D. Rondelli, F. Lauria, 1994, Blood.

First Global Blood & Marrow Transplant [GlobalBMT] Conference in Kathmandu with experiences from Nepal, India, Singapore and Sri Lanka

V. Mathews, D. Rondelli, L. Gooneratne, 2018, Journal of Global Health.

Acute Myeloid Leukemia With Myelodysplasia- Related Changes A New Entity Defined by the WHO 2008 Classification of Hematopoietic and Lymphoid Neoplasms

J. Quigley, D. Peace, D. Rondelli, 2009 .

American Society of Transplantation and Cellular Therapy International Affair Committee: Report of 3rd Workshop on Global Perspective to Access to Transplantation at the 2022 Tandem Meeting.

M. Flowers, A. Srivastava, S. Okamoto, 2023, Transplantation and cellular therapy.

Cord blood nucleated cells induce delayed T cell alloreactivity.

D. Mahmud, D. Rondelli, J. Abbasian, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type, in a Patient with a Constitutional 11q Terminal Deletion Disorder

D. Rondelli, A. Attele, S. Abutalib, 2007, Acta Haematologica.

Alpha-methyldopa-type autoimmune hemolytic anemia caused by lobenzarit disodium of a mefenamic acid derivative and immunomodulator.

S. Tura, D. Rondelli, F. Lauria, 1994 .

Bone Marrow Transplantation in Patients With Acute Leukemia In Cuba: Results From the Last 30 Years and New Opportunities Through International Collaboration

D. Rondelli, K. Sweiss, P. Patel, 2018, Journal of global oncology.

Bone-marrow biopsy in hairy cell leukaemia (HCL) patients. Histological and immunohistological analysis of 46 cases treated with different therapies.

S. Pileri, B. Falini, E. Sabattini, 1994, Leukemia & lymphoma.

Strength Training Following Hematopoietic Stem Cell Transplantation

D. Peace, E. Hacker, J. Larson, 2011, Cancer nursing.

Sequence and Expression Analysis Of The β-2-Microglobulin Gene In Dialysis Patients

P. Strippoli, S. Canaider, P. Carinci, 2002, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Antifungal prophylaxis with Amphotericin B deoxycholate emulsified in lipids for acute myeloid leukemia patients treated in low economy countries

B. Gyawali, G. Shrestha, D. Rondelli, 2016, Leukemia & lymphoma.

Decreased pulmonary function in asymptomatic long-term survivors after allogeneic hematopoietic stem cell transplant

S. Dudek, D. Rondelli, R. Chowdhery, 2016, Bone Marrow Transplantation.

Collaborative Physician-Pharmacist-Managed Multiple Myeloma Clinic Improves Guideline Adherence and Prevents Treatment Delays.

L. Sharp, D. Rondelli, K. Sweiss, 2018, Journal of oncology practice.

Clinical grade isolation of regulatory T cells from G-CSF mobilized peripheral blood improves with initial depletion of monocytes.

N. Mahmud, D. Mahmud, D. Rondelli, 2015, American journal of blood research.

The Bottom Line : Total marrow and lymphoid irradiation to rescue refractory leukemia

D. Rondelli, P. Patel, 2017 .

Voriconazole-Induced Periostitis Mimicking Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation

D. Rondelli, K. Sweiss, P. Patel, 2016, Case reports in infectious diseases.

Increased DNA Repair Gene Expression Correlates with MYC Expression and Inferior Progression-Free Survival in Multiple Myeloma Patients

C. Hofmeister, B. Barwick, D. Rondelli, 2020 .

Chronic opioid use can be reduced or discontinued after haematopoietic stem cell transplantation for sickle cell disease

V. Gordeuk, R. Molokie, Jin Han, 2020, British journal of haematology.

Rapidly established telehealth care for blood cancer patients in Nepal during the COVID-19 pandemic using the free app Viber

B. Gyawali, D. Rondelli, B. Poudyal, 2020, Ecancermedicalscience.

Preclinical IV busulfan dose-finding study to induce reversible myeloablation in a non-human primate model

N. Mahmud, D. Rondelli, K. Sweiss, 2018, PloS one.

Total Marrow and Lymphoid Irradiation to Rescue Refractory Leukemia.

D. Rondelli, P. Patel, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Combination of linear accelerator-based intensity-modulated total marrow irradiation and myeloablative fludarabine/busulfan: a phase I study.

R. Weichselbaum, N. Mahmud, D. Mahmud, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.